Publications
- Newest First
- Most Cited
- Most Discussed
Showing 1 - 100 results of 3,170 publications
2025
- GIT ArfGAP2: A Cytoskeletal Safeguard in Podocytes: Suppressing Rac1 to Combat Glomerular Injury.Ishibe S, Tian X. GIT ArfGAP2: A Cytoskeletal Safeguard in Podocytes: Suppressing Rac1 to Combat Glomerular Injury. J Am Soc Nephrol 2025 PMID: 40257840, DOI: 10.1681/ASN.0000000707.
- Editorial: Case reports in nephrology.Tian X, Ardiles L, Block CA. Editorial: Case reports in nephrology. Front Nephrol 2025, 5: 1595978. PMID: 40260144, DOI: 10.3389/fneph.2025.1595978.
- Early Pre-Emptive Kidney Transplant Does Not Offer Any Mortality Benefits: A Study of Trends in Pre-Emptive Kidney Transplantation Over the Last Two Decades.Kumar A, Bonnell L, Kuppachi S. Early Pre-Emptive Kidney Transplant Does Not Offer Any Mortality Benefits: A Study of Trends in Pre-Emptive Kidney Transplantation Over the Last Two Decades. Transplant Proc 2025 PMID: 40140312, DOI: 10.1016/j.transproceed.2025.02.032.
- Polycystic Kidney Disease in Children: The Current Status and the Next HorizonCadnapaphornchai M, Dell K, Gimpel C, Guay-Woodford L, Gulati A, Hartung E, Liebau M, Mallett A, Marlais M, Mekahli D, Piccirilli A, Seeman T, Tindal K, Winyard P. Polycystic Kidney Disease in Children: The Current Status and the Next Horizon. American Journal Of Kidney Diseases 2025 PMID: 40113156, DOI: 10.1053/j.ajkd.2025.01.022.
- The Value of EHR-Generated Recommendations for Treating Acute Kidney Injury—ReplyAklilu A, Menez S, Wilson F. The Value of EHR-Generated Recommendations for Treating Acute Kidney Injury—Reply. JAMA 2025, 333: 1006-1007. PMID: 39960729, DOI: 10.1001/jama.2024.27374.
- Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injuryBaker M, Cantley L. Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury. Journal Of Clinical Investigation 2025, 135: e188358. PMID: 40091836, PMCID: PMC11910233, DOI: 10.1172/jci188358.
- CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes.Sun Y, Kronenberg NM, Sethi S, Dash SN, Kovalik ME, Sempowski B, Strickland S, Raina R, Sperati CJ, Tian X, Ishibe S, Hall G, Gather MC. CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes. Am J Physiol Renal Physiol 2025 PMID: 40062402, DOI: 10.1152/ajprenal.00318.2024.
- Associations between Blood DNA Methylation and Histopathological Features in Lupus Nephritis.Demkowicz P, Kavaliauskaite I, Faulkner S, Kent C, Shaw M, Kumar D, Ix J, Wilson F, Moledina D, Bakhoum M, Bakhoum C. Associations between Blood DNA Methylation and Histopathological Features in Lupus Nephritis. Kidney360 2025 PMID: 40048255, DOI: 10.34067/kid.0000000758.
- World Kidney Day: Detecting Kidney Disease in Low- and Middle-Income CountriesWijewickrama E, Kalyesubula R. World Kidney Day: Detecting Kidney Disease in Low- and Middle-Income Countries. Kidney International Reports 2025, 10: 637-640. DOI: 10.1016/j.ekir.2025.01.016.
- I Brazilian guideline on hypertension in dialysis of the Brazilian Society of NephrologyRodrigues C, Ferreira-Filho S, de Souza Moura A, Poli-de-Figueiredo C, da Silva D, Polacchini F, de Almeida F, Pinheiro M, Bezerra R, de Paula R, Peixoto A, Figueiredo A, Feitosa A, Machado C, Amodeo C, Mion D, Muxfeldt E, da Silva G, Moura-Neto J, Pazeli J, Lotaif L, Drager L, Martín L, Bortolotto L, Bastos M, Malachias M, Moreira M, Canziani M, Miranda R, da Silva Franco R, Pecoits R, Mulinari R, Elias R, Barroso W, Nadruz W. I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology. Brazilian Journal Of Nephrology 2025, 47: e20240033. PMID: 40009791, PMCID: PMC11864789, DOI: 10.1590/2175-8239-jbn-2024-0033en.
- I Diretriz Brasileira de hipertensão arterial na diálise da Sociedade Brasileira de NefrologiaRodrigues C, Ferreira-Filho S, Moura A, Poli-de-Figueiredo C, Silva D, Polacchini F, Almeida F, Pinheiro M, Bezerra R, Paula R, Peixoto A, Figueiredo A, Feitosa A, Machado C, Amodeo C, Mion Junior D, Muxfeldt E, Silva G, Moura-Neto J, Pazeli Júnior J, Lotaif L, Drager L, Martín L, Bortolotto L, Bastos M, Malachias M, Moreira M, Canziani M, Miranda R, Franco R, Pecoits Filho R, Mulinari R, Elias R, Barroso W, Nadruz W. I Diretriz Brasileira de hipertensão arterial na diálise da Sociedade Brasileira de Nefrologia. Brazilian Journal Of Nephrology 2025, 47 DOI: 10.1590/2175-8239-jbn-2024-0033pt.
- Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist InterventionsManis M, Wallace J, Boyd E, Abebe K, Fried L, Palevsky P, Conway P, Horwitz E, Liu K, Parikh C, Poggio E, Siew E, Neyra J, Weir M, Wilson F, Kane-Gill S. Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist Interventions. Advances In Kidney Disease And Health 2025, 32: 154-161. PMID: 40222802, DOI: 10.1053/j.akdh.2025.01.005.
- Early Steroid Withdrawal in Kidney Transplant Recipients: PROVirmani S, Asch W. Early Steroid Withdrawal in Kidney Transplant Recipients: PRO. Kidney360 2025, 6: 191-193. PMID: 40014439, PMCID: PMC11882247, DOI: 10.34067/kid.0000000000000326.
- Renalase levels are decreased in maternal blood and placental tissues in pregnancies associated with preterm preeclampsiaSoliman Y, Eke C, Guo X, Wang M, Silva T, Désir G, Konnikova L. Renalase levels are decreased in maternal blood and placental tissues in pregnancies associated with preterm preeclampsia. Scientific Reports 2025, 15: 6480. PMID: 39987333, PMCID: PMC11846959, DOI: 10.1038/s41598-025-90524-z.
- Volumetric imaging of the 3D orientation of cellular structures with a polarized fluorescence light-sheet microscopeChandler T, Guo M, Su Y, Chen J, Wu Y, Liu J, Agashe A, Fischer R, Mehta S, Kumar A, Baskin T, Jaumouillé V, Liu H, Swaminathan V, Nain A, Oldenbourg R, La Riviere P, Shroff H. Volumetric imaging of the 3D orientation of cellular structures with a polarized fluorescence light-sheet microscope. Proceedings Of The National Academy Of Sciences Of The United States Of America 2025, 122: e2406679122. PMID: 39982748, PMCID: PMC11874040, DOI: 10.1073/pnas.2406679122.
- Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trialIscoe M, Hooper C, Levy D, Buchanan L, Dziura J, Meeker D, Taylor R, D’Onofrio G, Oladele C, Sarpong D, Paek H, Wilson F, Heagerty P, Delgado M, Hoppe J, Melnick E. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open 2025, 15: e098072. PMID: 39979056, PMCID: PMC11842997, DOI: 10.1136/bmjopen-2024-098072.
- Will Patients With Acute Interstitial Nephritis Recover? Insights From a New Biopsy SeriesQian L, Moledina D. Will Patients With Acute Interstitial Nephritis Recover? Insights From a New Biopsy Series. 2025, 17: 17. DOI: 10.62716/kn.000322024.
- Induction of Immune Tolerance in Living Related HLA-Matched Kidney Transplantation: A Phase 3 Randomized Clinical TrialKaufman D, Akkina S, Stegall M, Piper J, Gaber A, Asch W, Busque S, Stites E, De Vera M, Srinivas T, Alonso D, Shah A, Patel A, L. M, Chavin K, DebRoy M, Jittirat A, Costa N, Cooper M, Vranic G, Laftavi M, Saidi R, Collette S, Brennan D, Group M. Induction of Immune Tolerance in Living Related HLA-Matched Kidney Transplantation: A Phase 3 Randomized Clinical Trial. American Journal Of Transplantation 2025 PMID: 39922283, DOI: 10.1016/j.ajt.2025.01.044.
- Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants.Jawaid T, Elbarougy D, Lavu S, Buia G, Senum S, Olinger E, Yang H, McDonnell S, Bublitz J, Ma J, Audrézet M, Madsen C, Schauer R, Baker T, Gregory A, Orr S, Barroso-Gil M, Neatu R, Joli G, Dahl N, Kline T, Gillion V, Dahan K, Jouret F, Perrone R, Steinman T, Peters D, Gitomer B, Watnick T, Coto E, Chebib F, Hogan M, Olson J, Larson N, Ars E, Halbritter J, Demoulin N, Torres V, Sayer J, Cornec-Le Gall E, Harris P. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. Journal Of The American Society Of Nephrology 2025 PMID: 39899384, DOI: 10.1681/asn.0000000613.
- WCN25-2967 PREVALENCE, AWARENESS AND FACTORS ASSOCIATED WITH HYPERTENSION AMONG ADULTS IN RURAL SOUTH-WESTERN UGANDA: A CROSS-SECTIONAL STUDYKansiime G, Nuwagira E, Obwoya P, Baluku J, Kanyesigye M, Twesiime C, Ssebutunde C, Muhindo R, Muyingo A, Kananura K, Tusingwire P, Atukunda E, Kalyesubula R, Bajunirwe F, Muiru A. WCN25-2967 PREVALENCE, AWARENESS AND FACTORS ASSOCIATED WITH HYPERTENSION AMONG ADULTS IN RURAL SOUTH-WESTERN UGANDA: A CROSS-SECTIONAL STUDY. Kidney International Reports 2025, 10: s346. DOI: 10.1016/j.ekir.2024.11.640.
- Is Intravenous Contrast-Associated Acute Kidney Injury a Significant Problem and Are Risk Scores Useful?Perazella M. Is Intravenous Contrast-Associated Acute Kidney Injury a Significant Problem and Are Risk Scores Useful? Kidney360 2025, 6: 9-11. PMID: 40146910, PMCID: PMC11793183, DOI: 10.34067/kid.0000000636.
- Chronic kidney diseaseRomagnani P, Agarwal R, Chan J, Levin A, Kalyesubula R, Karam S, Nangaku M, Rodríguez-Iturbe B, Anders H. Chronic kidney disease. Nature Reviews Disease Primers 2025, 11: 8. PMID: 39885176, DOI: 10.1038/s41572-024-00589-9.
- Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySinha S, Dwivedi N, Tao S, Jamadar A, Kakade V, O’ Neil M, Weiss R, Enders J, Calvet J, Thomas S, Rao R. Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. Oncogene 2025, 44: 632-633. PMID: 39870786, DOI: 10.1038/s41388-025-03279-2.
- The Economic Value of Volunteers Directing and Managing the US Organ Donation and Transplantation SystemLevan M, Flower T, Massie A, Rudow D, Sidoti C, Formica R, Ratner L. The Economic Value of Volunteers Directing and Managing the US Organ Donation and Transplantation System. Transplantation 2025, 109: e184-e185. PMID: 39865535, DOI: 10.1097/tp.0000000000005293.
- The prognostic relevance of donor-specific antibodies in facial transplantation – A retrospective cohort studyHuelsboemer L, Hosseini H, Klimitz F, Diatta F, Boroumand S, O'Brien C, Parikh N, Stögner V, Formica R, Ko C, Azzi J, Draper E, Lian C, Murphy G, Pomahac B, Kauke-Navarro M. The prognostic relevance of donor-specific antibodies in facial transplantation – A retrospective cohort study. Journal Of Plastic Reconstructive & Aesthetic Surgery 2025, 103: 286-296. PMID: 40043533, DOI: 10.1016/j.bjps.2025.01.028.
- Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working GroupGeertsema P, Gansevoort R, Arici M, Capasso G, Gall E, Furlano M, Fuster D, Galletti F, Dos Santos V, Gomez M, Goumenos D, Halbritter J, Jambon E, Korst U, Leliveld-Kors A, Musquera M, Figueiredo A, Nijenhuis T, Olsburgh J, Pol R, Sayer J, Stippel D, Torra R, Müller R, Casteleijn N, Alam A, Bammens B, Bartram M, Birn H, Budde K, Cakiroglu F, Castro-Alonso C, Chebib F, Dahl N, de Almeida E, Demoulin N, Devuyst O, Eleftheriadis T, Prlic M, Horie S, Idrizi A, Iyasere O, Janssens P, Jouret F, Luque Y, Mallett A, Mousseaux C, Mrug M, Perrone R, Reiterova J, Robles N, Rroji M, Rudnicki M, Schmitt R, Scolari F, Tesar V, Topaloglu R, Trillini M, Weekers L, Zakrocka I, Spahia N, Kawano H, Muto S. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group. Nephrology Dialysis Transplantation 2025, gfaf019. PMID: 39848914, DOI: 10.1093/ndt/gfaf019.
- Biomarker Panels for Discriminating Risk of CKD Progression in Children.Greenberg J, Abraham A, Xu Y, Schelling J, Coca S, Schrauben S, Wilson F, Waikar S, Vasan R, Gutierrez O, Shlipak M, Ix J, Warady B, Kimmel P, Bonventre J, Parikh C, Denburg M, Furth S. Biomarker Panels for Discriminating Risk of CKD Progression in Children. Journal Of The American Society Of Nephrology 2025 PMID: 39820177, DOI: 10.1681/asn.0000000602.
- Medicare Coverage and Patient Out-of-Pocket Costs for MavacamtenBansal K, Chien C, Masri A, Riello R, Ahmad T, Desai N, Dani S. Medicare Coverage and Patient Out-of-Pocket Costs for Mavacamten. Circulation Cardiovascular Quality And Outcomes 2025, 18: e011331. PMID: 39817331, DOI: 10.1161/circoutcomes.124.011331.
- Managing risk factors and early intervention for chronic kidney diseaseKalyesubula R, Luyckx V. Managing risk factors and early intervention for chronic kidney disease. Nature Reviews Nephrology 2025, 21: 149-150. PMID: 39814983, DOI: 10.1038/s41581-025-00930-9.
- Glucarpidase for Treatment of High-Dose Methotrexate ToxicityGupta S, Kaunfer S, Chen K, Dias J, Vijayan A, Rajasekaran A, Prosek J, Truong H, Wood A, Bassil C, Renaghan A, Shah C, Zhang J, Glezerman I, Carlos C, Kelly K, Passero C, Drappatz J, Abudayyeh A, Shin D, Sperati C, Yelvington B, Kanduri S, Neyra J, Edmonston D, Shirali A, Bansal A, Geara A, Mithani Z, Ziolkowski S, Rashidi A, Jakubowski J, Pujari A, Bond D, Dotson E, Wall S, Patton J, Barreto J, Herrmann S, Sheikh M, Baz R, Lee J, Lucchesi N, Kolman M, Rasheed M, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller R, Velez J, Flannery A, Aklilu A, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam O, Wells S, Ortega J, Green-Lingren O, Leaf R, Sise M, Nayak L, LaCasce A, Leung N, Leaf D. Glucarpidase for Treatment of High-Dose Methotrexate Toxicity. Blood 2025 PMID: 39760780, DOI: 10.1182/blood.2024026211.
- Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionJin K, Ding Y, Xu J, Liu Z, Zeng H, Su X, Zhang L, Sun J, Wu Y, Liu H, Chang Y, Zhu Y, Wang Z, Xu L, Zhang W, Xu J. Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression. Journal For ImmunoTherapy Of Cancer 2025, 13: e010964. PMID: 39762080, PMCID: PMC11749520, DOI: 10.1136/jitc-2024-010964.
- Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traitsScherer N, Fässler D, Borisov O, Cheng Y, Schlosser P, Wuttke M, Haug S, Li Y, Telkämper F, Patil S, Meiselbach H, Wong C, Berger U, Sekula P, Hoppmann A, Schultheiss U, Mozaffari S, Xi Y, Graham R, Schmidts M, Köttgen M, Oefner P, Knauf F, Eckardt K, Grünert S, Estrada K, Thiele I, Hertel J, Köttgen A. Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nature Genetics 2025, 57: 193-205. PMID: 39747595, PMCID: PMC11735408, DOI: 10.1038/s41588-024-01965-7.
- Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisGunes I, Bernstein E, Cowper S, Panse G, Pradhan N, Camacho L, Page N, Bundschuh E, Williams A, Carns M, Aren K, Fantus S, Volkmann E, Bukiri H, Correia C, Kolachalama V, Wilson F, Mawe S, Mahoney J, Hinchcliff M. Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis. Arthritis Research & Therapy 2025, 27: 85. PMID: 40217251, DOI: 10.1186/s13075-025-03508-9.
2024
- Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney InjuryAklilu A, Menez S, Baker M, Brown D, Dircksen K, Dunkley K, Gaviria S, Farrokh S, Faulkner S, Jones C, Kadhim B, Le D, Li F, Makhijani A, Martin M, Moledina D, Coronel-Moreno C, O’Connor K, Shelton K, Shvets K, Srialluri N, Tan J, Testani J, Corona-Villalobos C, Yamamoto Y, Parikh C, Wilson F, Sundararajan A, Wang A, Schretlen C, Singel D, Moss E, Aune F, Iantosca G, Zou G, Chernova I, Bitzel J, Hernandez J, Lindsley J, Dane K, Orias M, Mehta P, Zassman-Isner S, Wen Y, Freeman N. Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury. JAMA 2024, 332: 2081-2090. PMID: 39454050, PMCID: PMC11669049, DOI: 10.1001/jama.2024.22718.
- Preparing for stormy weather: building VA health system resilience for dialysis emergency preparedness in the era of climate changeMartin D, Brewster P, Crowley S. Preparing for stormy weather: building VA health system resilience for dialysis emergency preparedness in the era of climate change. Current Opinion In Nephrology & Hypertension 2024, 34: 156-163. PMID: 39699057, DOI: 10.1097/mnh.0000000000001054.
- Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury SurvivorsMenez S, Kerr K, Cheng S, Hu D, Thiessen-Philbrook H, Moledina D, Mansour S, Go A, Ikizler T, Kaufman J, Kimmel P, Himmelfarb J, Coca S, Parikh C. Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. Clinical Journal Of The American Society Of Nephrology 2024, 20: 337-345. PMID: 39671257, PMCID: PMC11906013, DOI: 10.2215/cjn.0000000622.
- Acute Kidney Injury in Patients with Cirrhosis and Chronic Kidney Disease: Results from the HRS-HARMONY ConsortiumSt. Hillien S, Robinson J, Ouyang T, Patidar K, Belcher J, Cullaro G, Regner K, Chung R, Ufere N, Velez J, Neyra J, Asrani S, Wadei H, Teixeira J, Saly D, Levitsky J, Orman E, Sawinski D, Dageforde L, Allegretti A, Consortium H. Acute Kidney Injury in Patients with Cirrhosis and Chronic Kidney Disease: Results from the HRS-HARMONY Consortium. Clinical Gastroenterology And Hepatology 2024 PMID: 39675402, DOI: 10.1016/j.cgh.2024.10.023.
- Fostering international coordination in renal disaster preparedness: a collaboration between the Renal Disaster Preparedness Working Group of the International Society of Nephrology and the Disaster Preparedness and Response Committee of the Korean Society of NephrologyYoo K, Lee S, Park H, Hwang W, Lee J, Liew A, Abu-Alfa A, Park H, Lee Y. Fostering international coordination in renal disaster preparedness: a collaboration between the Renal Disaster Preparedness Working Group of the International Society of Nephrology and the Disaster Preparedness and Response Committee of the Korean Society of Nephrology. Kidney Research And Clinical Practice 2024, 43: 832-835. PMID: 39622276, PMCID: PMC11615451, DOI: 10.23876/j.krcp.24.222.
- Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in UgandaNasuuna E, Tomlinson L, Kalyesubula R, Dziva Chikwari C, Castelnuovo B, Manabe Y, Nakanjako D, Weiss H. Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in Uganda. BMC Nephrology 2024, 25: 422. PMID: 39587464, PMCID: PMC11590532, DOI: 10.1186/s12882-024-03865-8.
- Treatment Effect Heterogeneity in Acute Kidney Injury Incidence Following Intravenous Antihypertensive Administration for Severe Blood Pressure Elevation During HospitalizationGhazi L, Chen X, Harhay M, Hu L, Biswas A, Peixoto A, Li F, Wilson F. Treatment Effect Heterogeneity in Acute Kidney Injury Incidence Following Intravenous Antihypertensive Administration for Severe Blood Pressure Elevation During Hospitalization. American Journal Of Kidney Diseases 2024, 85: 442-453. PMID: 39580068, DOI: 10.1053/j.ajkd.2024.09.011.
- Re-Evaluating the Transplant Glomerulopathy Lesion—Beyond Donor-Specific AntibodiesChutani A, Guevara-Pineda D, Lerner G, Menon M. Re-Evaluating the Transplant Glomerulopathy Lesion—Beyond Donor-Specific Antibodies. Transplant International 2024, 37: 13365. PMID: 39640250, PMCID: PMC11617188, DOI: 10.3389/ti.2024.13365.
- Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with CancerMistry K, Sadarangani S, Moreno D, Mejia S, Moledina D, Sise M. Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with Cancer. Kidney360 2024, 6: 167-174. PMID: 39575585, PMCID: PMC11793192, DOI: 10.34067/kid.0000000660.
- Incremental hemodialysis transition in veterans and nonveterans with kidney failureRhee C, Kovesdy C, Unruh M, Crowley S, Geller D, Goldfarb D, Kraut J, Rastegar M, Rifkin I, Kalantar-Zadeh K. Incremental hemodialysis transition in veterans and nonveterans with kidney failure. Current Opinion In Nephrology & Hypertension 2024, 34: 33-40. PMID: 39611277, DOI: 10.1097/mnh.0000000000001040.
- KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKDNavaneethan S, Bansal N, Cavanaugh K, Chang A, Crowley S, Delgado C, Estrella M, Ghossein C, Ikizler T, Koncicki H, St Peter W, Tuttle K, William J. KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal Of Kidney Diseases 2024, 85: 135-176. PMID: 39556063, DOI: 10.1053/j.ajkd.2024.08.003.
- Development of a Novel Intraperitoneal Icodextrin/Dextrose Solution for Enhanced Sodium RemovalAsher J, Ivey-Miranda J, Maulion C, Cox Z, Borges-Vela J, Mendoza-Zavala G, Cigarroa-Lopez J, Silva-Rueda R, Revilla-Monsalve C, Moreno-Villagomez J, Ramos-Mastache D, Goedje O, Crosbie I, McIntyre C, Finkelstein F, Turner J, Testani J, Rao V. Development of a Novel Intraperitoneal Icodextrin/Dextrose Solution for Enhanced Sodium Removal. Kidney Medicine 2024, 7: 100938. PMID: 39790231, PMCID: PMC11714391, DOI: 10.1016/j.xkme.2024.100938.
- Tolvaptan and Autosomal Dominant Polycystic Kidney Disease Progression in Individuals Aged 18-35 Years: A Pooled Database AnalysisChebib F, Dahl N, Zhou X, Garbinsky D, Wang J, Nunna S, Oberdhan D, Fernandes A. Tolvaptan and Autosomal Dominant Polycystic Kidney Disease Progression in Individuals Aged 18-35 Years: A Pooled Database Analysis. Kidney Medicine 2024, 7: 100935. PMID: 39810815, PMCID: PMC11731472, DOI: 10.1016/j.xkme.2024.100935.
- Abstract 4142323: Access to Lipid-Lowering Therapies is Limited by Payer Coverage Restrictions and High Out-of-Pocket Costs on Medicare Prescription Drug PlansYoung G, Bansal K, Riello R, Faridi K, Clark K, Desai N. Abstract 4142323: Access to Lipid-Lowering Therapies is Limited by Payer Coverage Restrictions and High Out-of-Pocket Costs on Medicare Prescription Drug Plans. Circulation 2024, 150: a4142323-a4142323. DOI: 10.1161/circ.150.suppl_1.4142323.
- Abstract 4146297: Cardiovascular Risk Prediction with the Kidney Failure Risk Equation Among Patients with Chronic Kidney Disease: Insights from CRICCorrea S, Beldhuis I, Neuen B, Vaduganathan M, Wilson F, Mc Causland F. Abstract 4146297: Cardiovascular Risk Prediction with the Kidney Failure Risk Equation Among Patients with Chronic Kidney Disease: Insights from CRIC. Circulation 2024, 150: a4146297-a4146297. DOI: 10.1161/circ.150.suppl_1.4146297.
- Efficient and selective kidney targeting by chemically modified carbohydrate conjugatesKumar V, Wahane A, Tham M, Somlo S, Gupta A, Bahal R. Efficient and selective kidney targeting by chemically modified carbohydrate conjugates. Molecular Therapy 2024, 32: 4383-4400. PMID: 39532098, PMCID: PMC11638880, DOI: 10.1016/j.ymthe.2024.10.020.
- Adamts1 and Cyst Expansion in Polycystic Kidney Disease.Kakade V, Akman Z, Motrapu M, Cassini M, Xu L, Moeckel G, Somlo S, Cantley L. Adamts1 and Cyst Expansion in Polycystic Kidney Disease. Journal Of The American Society Of Nephrology 2024 PMID: 39514301, DOI: 10.1681/asn.0000000557.
- External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis.Moledina D, Shelton K, Menez S, Aklilu A, Yamamoto Y, Kadhim B, Shaw M, Kent C, Makhijani A, Hu D, Simonov M, O'Connor K, Bitzel J, Thiessen-Philbrook H, Wilson F, Parikh C. External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis. Journal Of The American Society Of Nephrology 2024 PMID: 39500309, DOI: 10.1681/asn.0000000556.
- Prevalence of chronic kidney disease among young people living with HIV in Sub Saharan Africa: A systematic review and meta-analysisNasuuna E, Nanyeenya N, Kibirige D, Izudi J, Chikwari C, Kalyesubula R, Castelnuovo B, Tomlinson L, Weiss H. Prevalence of chronic kidney disease among young people living with HIV in Sub Saharan Africa: A systematic review and meta-analysis. PLOS ONE 2024, 19: e0301954. PMID: 39495780, PMCID: PMC11534254, DOI: 10.1371/journal.pone.0301954.
- Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patientsHardenberg J, Kunz J, Rubarth K, Mittermaier M, Pigorsch M, Balzer F, Witzenrath M, Hinz R, Körner R, Eckardt K, Knauf F, Hinrichs C, Enghard P. Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients. Clinical Kidney Journal 2024, 17: sfae328. PMID: 39582778, PMCID: PMC11584513, DOI: 10.1093/ckj/sfae328.
- Autosomal Dominant Polycystic Kidney DiseaseSuarez M, Titan S, Dahl N. Autosomal Dominant Polycystic Kidney Disease. Advances In Kidney Disease And Health 2024, 31: 496-503. PMID: 39577883, DOI: 10.1053/j.akdh.2024.07.003.
- Using Overlap Weights to Address Extreme Propensity Scores in Estimating Restricted Mean Counterfactual Survival TimesCao Z, Ghazi L, Mastrogiacomo C, Forastiere L, Wilson F, Li F. Using Overlap Weights to Address Extreme Propensity Scores in Estimating Restricted Mean Counterfactual Survival Times. American Journal Of Epidemiology 2024, kwae416. PMID: 39489504, DOI: 10.1093/aje/kwae416.
- Ten-year follow-up after face transplantation—A single-center retrospective cohort studyHuelsboemer L, Kauke-Navarro M, Boroumand S, Parikh N, Hosseini H, Yu C, Stögner V, Ko C, Perry B, Formica R, Hung P, Mahajan A, Azzi J, Murphy G, Pomahac B. Ten-year follow-up after face transplantation—A single-center retrospective cohort study. American Journal Of Transplantation 2024, 25: 611-622. PMID: 39413877, DOI: 10.1016/j.ajt.2024.10.007.
- Global Perspective on Acute Kidney Injury in UgandaKansiime G, Langoya D, Kalyesubula R. Global Perspective on Acute Kidney Injury in Uganda. Kidney360 2024, 6: 152-155. PMID: 39378101, PMCID: PMC11793190, DOI: 10.34067/kid.0000000611.
- A-058 Biomarkers of Nephropathy and the Angiotensin Converting Enzyme Insertion and Deletion Gene Polymorphisms Among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital in UgandaKiconco R, Kalyesubula R, Kiwanuka G. A-058 Biomarkers of Nephropathy and the Angiotensin Converting Enzyme Insertion and Deletion Gene Polymorphisms Among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital in Uganda. Clinical Chemistry 2024, 70: hvae106.057. DOI: 10.1093/clinchem/hvae106.057.
- B-243 Validating a highly automated, rapid turnaround urine biomarker assay for diagnosis of acute interstitial nephritisObeid W, Moledina D, Parikh C. B-243 Validating a highly automated, rapid turnaround urine biomarker assay for diagnosis of acute interstitial nephritis. Clinical Chemistry 2024, 70: hvae106.600. DOI: 10.1093/clinchem/hvae106.600.
- Structured Application of Nephrogenetics in a Pediatric Kidney Clinic Is Clinically Impactful and ChallengingSalcedo-Giraldo J, Wink K, Freiman A, Guay-Woodford L, Pyle L, Gulati A. Structured Application of Nephrogenetics in a Pediatric Kidney Clinic Is Clinically Impactful and Challenging. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024781ket02. DOI: 10.1681/asn.2024781ket02.
- Unmasking the Mimickers: HNF1B Variants in Pediatric Kidney DiseasesSalcedo-Giraldo J, Wink K, Freiman A, Pyle L, Gulati A. Unmasking the Mimickers: HNF1B Variants in Pediatric Kidney Diseases. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024ng1r16ak. DOI: 10.1681/asn.2024ng1r16ak.
- Ryanodine Receptor 3 (RYR3) as a Candidate Modifier of Aneurysm Formation in ADPKDRoy K, Gulati A, Gu J, Shaw M, Sun Z, Besse W, Watnick T, Somlo S. Ryanodine Receptor 3 (RYR3) as a Candidate Modifier of Aneurysm Formation in ADPKD. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024xfh9af06. DOI: 10.1681/asn.2024xfh9af06.
- Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)Wei Z, Tian X, Rehman M, Dong K, Cai Y, Cordido A, Somlo S. Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD). Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024x2zerq4t. DOI: 10.1681/asn.2024x2zerq4t.
- Chemical Modulation of the Ire1α-Xbp1 Pathway Reduces Cyst Size in ADPKD Mouse and Human Three-Dimensional SpheroidsHasan F, Bhardwaj R, Rehman M, Cai Y, Dong K, Cordido A, Pioppini C, Yilmaz D, Tian X, Somlo S, Krappitz M, Fedeles S. Chemical Modulation of the Ire1α-Xbp1 Pathway Reduces Cyst Size in ADPKD Mouse and Human Three-Dimensional Spheroids. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024x8qpvhm3. DOI: 10.1681/asn.2024x8qpvhm3.
- Analysis of Kidney Biopsies from Patients with Glomerulonephritis Using Imaging Mass Cytometry Reveals Increase in Immune Cells with Associated Dedifferentiation and Injury of Tubular CellsWeiss M, Kakade V, Baker M, Budiman T, Shelar A, Cantley L. Analysis of Kidney Biopsies from Patients with Glomerulonephritis Using Imaging Mass Cytometry Reveals Increase in Immune Cells with Associated Dedifferentiation and Injury of Tubular Cells. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.202490mzwbkc. DOI: 10.1681/asn.202490mzwbkc.
- Understanding Pathophysiology of Acute Interstitial Nephritis through Spatial Characterization of Cell-Cell Interactions Using Imaging Mass Cytometry in a Human Biopsy CohortBaker M, Kakade V, Budiman T, Weiss M, Shelar A, Moledina D, Cantley L. Understanding Pathophysiology of Acute Interstitial Nephritis through Spatial Characterization of Cell-Cell Interactions Using Imaging Mass Cytometry in a Human Biopsy Cohort. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024n6j4nxq1. DOI: 10.1681/asn.2024n6j4nxq1.
- Effect of Cessation of Renin-Angiotensin System Inhibitors on Clinical Outcomes in AKIMakhijani A, Yasmin F, Moledina D, Yamamoto Y, Wilson F. Effect of Cessation of Renin-Angiotensin System Inhibitors on Clinical Outcomes in AKI. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024xcwjpmwx. DOI: 10.1681/asn.2024xcwjpmwx.
- Clinical Predictors of Fluid-Responsive AKINguyen C, Aklilu A, Yamamoto Y, Coronel-Moreno C, Kadhim B, Wilson F. Clinical Predictors of Fluid-Responsive AKI. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024k7pcazfe. DOI: 10.1681/asn.2024k7pcazfe.
- Macrophage Infusion Rescues Cisplatin (CP)-Induced AKIGuo X, Xu L, Velazquez H, Chen T, Safirstein R, Desir G. Macrophage Infusion Rescues Cisplatin (CP)-Induced AKI. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024psy855fx. DOI: 10.1681/asn.2024psy855fx.
- Adjudication of Kidney Biopsy Histopathology to Establish Consensus Diagnosis of Tubulointerstitial NephritisSadarangani S, Shaw M, Moeckel G, Kumar D, Kuperman M, Rosenberg A, Luciano R, Menez S, Perazella M, Wilson F, Makhijani A, Shelton K, Parikh C, Moledina D. Adjudication of Kidney Biopsy Histopathology to Establish Consensus Diagnosis of Tubulointerstitial Nephritis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20241qexcb21. DOI: 10.1681/asn.20241qexcb21.
- Blood DNA Methylation Is Associated with Histopathological Changes in Patients with Lupus NephritisBakhoum C, Demkowicz P, Kumar D, Ix J, Moledina D, Bakhoum M. Blood DNA Methylation Is Associated with Histopathological Changes in Patients with Lupus Nephritis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024bqw1nbby. DOI: 10.1681/asn.2024bqw1nbby.
- Shroom3-Rock Interaction and Profibrotic Function: Resolving the Mechanism of a CKD Genome-Wide Association Study Risk AlleleReghuvaran A, Kumar A, Barsotti G, Pell J, Tanvir E, He J, Menon M. Shroom3-Rock Interaction and Profibrotic Function: Resolving the Mechanism of a CKD Genome-Wide Association Study Risk Allele. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024qmq3drgr. DOI: 10.1681/asn.2024qmq3drgr.
- Genetic and Clinical Characterization of Patients with ADPKD and Intracranial Aneurysms: The PKD-VASC CohortPatel P, Besse W, Gulati A, Shaw M, Blumenfeld J, Pei Y, Gitomer B, Perrone R, Caliskan Y, Park H, Yu A, Dahl N, Rahbari-Oskoui F, Somlo S, Watnick T. Genetic and Clinical Characterization of Patients with ADPKD and Intracranial Aneurysms: The PKD-VASC Cohort. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024pma0ae6c. DOI: 10.1681/asn.2024pma0ae6c.
- Functional Studies of Polycystin-1 Using a Novel Pkd1-HaloTag MouseCordido A, Dong K, Cai Y, Tian X, Wei Z, Rehman M, Somlo S. Functional Studies of Polycystin-1 Using a Novel Pkd1-HaloTag Mouse. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024kjqymtyt. DOI: 10.1681/asn.2024kjqymtyt.
- Using Imaging Mass Cytometry to Define Cell Identities in AKI and CKD in HumansBudiman T, Shelar A, Baker M, Weiss M, Cantley L, Kakade V. Using Imaging Mass Cytometry to Define Cell Identities in AKI and CKD in Humans. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024g4m5sdnf. DOI: 10.1681/asn.2024g4m5sdnf.
- Tubule-Specific Deletion of Adamts1 Slows Cyst Expansion in Polycystic Kidney DiseaseKakade V, Akman Z, Motrapu M, Cantley L. Tubule-Specific Deletion of Adamts1 Slows Cyst Expansion in Polycystic Kidney Disease. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20246ecyxtfs. DOI: 10.1681/asn.20246ecyxtfs.
- Development of Urinalysis Screening Criteria for Electronic Health Alerts for RhabdomyolysisYasmin F, Faulkner S, Aklilu A, Yamamoto Y, Moledina D, Wilson F. Development of Urinalysis Screening Criteria for Electronic Health Alerts for Rhabdomyolysis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024bb8bw9yb. DOI: 10.1681/asn.2024bb8bw9yb.
- Personalized Recommendations for AKI Using a Kidney Action Team: A Multicenter Randomized Controlled TrialAklilu A, Menez S, Yamamoto Y, Bitzel J, Villalobos C, O'Connor K, Shelton K, Faulkner S, Makhijani A, Kadhim B, Parikh C, Wilson F. Personalized Recommendations for AKI Using a Kidney Action Team: A Multicenter Randomized Controlled Trial. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024gjjnbwvc. DOI: 10.1681/asn.2024gjjnbwvc.
- Myofibroblast-Macrophage Cross-Talk Supports Proliferative Tubule Repair after Kidney InjuryBharathan B, Xu L, Guo J, Cantley L. Myofibroblast-Macrophage Cross-Talk Supports Proliferative Tubule Repair after Kidney Injury. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20249phzkecs. DOI: 10.1681/asn.20249phzkecs.
- AKI in the Kidney Precision Medicine Project: Acute Tubular Injury vs. Acute Interstitial NephritisSchaub J, Castro A, Menez S, Wen Y, Menon R, Bhatraju P, Wilson F, Coca S, Eadon M, Bomback A, Moledina D, Cantley L, Palevsky P, D'Agati V, Randhawa P, Murugan R, Alpers C, Kretzler M, Himmelfarb J, Parikh C. AKI in the Kidney Precision Medicine Project: Acute Tubular Injury vs. Acute Interstitial Nephritis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024cxh8wvky. DOI: 10.1681/asn.2024cxh8wvky.
- Characterization of IFT140 Phenotype in Patients with ADPKD Using Advanced Imaging BiomarkersGhanem A, Debeh F, Borghol A, Paul S, Alkhatib B, Nader N, Gregory A, Yang H, Hanna C, Dahl N, Kline T, Harris P, Chebib F. Characterization of IFT140 Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20240vzj2pha. DOI: 10.1681/asn.20240vzj2pha.
- Phenotypic Characterization of Patients with ADPKD with PKD1 and PKD2 Pathogenic Variants Using Advanced Imaging BiomarkersBorghol A, Debeh F, Ghanem A, Paul S, Alkhatib B, Nader N, Gregory A, Yang H, Hanna C, Dahl N, Kline T, Harris P, Chebib F. Phenotypic Characterization of Patients with ADPKD with PKD1 and PKD2 Pathogenic Variants Using Advanced Imaging Biomarkers. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024jkdywd8g. DOI: 10.1681/asn.2024jkdywd8g.
- Risk vs. Reward: Impact of Kidney Biopsies on the Management of Critically Ill PatientsLlama A, Sadarangani S, Moledina D, Luciano R. Risk vs. Reward: Impact of Kidney Biopsies on the Management of Critically Ill Patients. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024dd7bnz12. DOI: 10.1681/asn.2024dd7bnz12.
- Hepatorenal Syndrome-AKI Reversal and Liver Transplant Rates in Patients Treated with TerlipressinBelcher J, Regner K, Subramanian R, Mujtaba M, Allegretti A, Cardoza S, Wadei H. Hepatorenal Syndrome-AKI Reversal and Liver Transplant Rates in Patients Treated with Terlipressin. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024934zvv6h. DOI: 10.1681/asn.2024934zvv6h.
- Cryoglobulinemic Glomerulonephritis Masquerading as IgA Nephropathy in a Patient with Crohn DiseaseAlshihri S, Lerner G, Llama A, Asch W. Cryoglobulinemic Glomerulonephritis Masquerading as IgA Nephropathy in a Patient with Crohn Disease. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024p54433ks. DOI: 10.1681/asn.2024p54433ks.
- Declining Serum Albumin in the Shadow of Stable Body Mass Index: A Mortality Indicator in Predialysis CKDSarav M, Shrestha P, Naseer A, Thomas F, Sumida K, Kalantar-Zadeh K, Kovesdy C. Declining Serum Albumin in the Shadow of Stable Body Mass Index: A Mortality Indicator in Predialysis CKD. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024f9m577ph. DOI: 10.1681/asn.2024f9m577ph.
- Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?Hu J, Schwann A, Tan J, Nuqali A, Riello R, Beasley M. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter? Heart Failure Clinics 2024, 20: 373-386. PMID: 39216923, DOI: 10.1016/j.hfc.2024.06.004.
- Role of Valosin-Containing Protein (VCP) in Ciliary Morphology and ADPKD: Exploring VCP as a Novel Genetic Interactor in Disease ProgressionPioppini C, Bhardwaj R, Fedeles S, Yilmaz D, Krappitz M. Role of Valosin-Containing Protein (VCP) in Ciliary Morphology and ADPKD: Exploring VCP as a Novel Genetic Interactor in Disease Progression. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024w6rq11tc. DOI: 10.1681/asn.2024w6rq11tc.
- Qualitative Analysis and Comparison of Externally Led, Patient-Focused Drug Development (EL-PFDD) Concepts for Autosomal Recessive Polycystic Kidney Disease (ARPKD) against Standardized Outcomes in Nephrology (SONG) InitiativesSoyfer B, Fedeles S, Vanasco W, Perrone R, Liebau M, Hartung E, Dell K, Guay-Woodford L, Hoover E, Oberdhan D. Qualitative Analysis and Comparison of Externally Led, Patient-Focused Drug Development (EL-PFDD) Concepts for Autosomal Recessive Polycystic Kidney Disease (ARPKD) against Standardized Outcomes in Nephrology (SONG) Initiatives. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024fj4z3w71. DOI: 10.1681/asn.2024fj4z3w71.
- Segment-Specific Cyst Index (SSCI): A Quantitative Analysis of Segment-Specific Responses during CystogenesisAkman Z, Kakade V, Cantley L. Segment-Specific Cyst Index (SSCI): A Quantitative Analysis of Segment-Specific Responses during Cystogenesis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024mpmapkd5. DOI: 10.1681/asn.2024mpmapkd5.
- Navigating Atypical Hemolytic Uremic Syndrome (aHUS) in PregnancyHoteit M, KFoury H, Abu-Alfa A. Navigating Atypical Hemolytic Uremic Syndrome (aHUS) in Pregnancy. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20247c4ezt6v. DOI: 10.1681/asn.20247c4ezt6v.
- Urine Proteomic Signatures of Kidney Function Decline after HospitalizationWen Y, Menez S, Philbrook H, Moledina D, Bhatraju P, Coca S, Chinchilli V, Go A, Siew E, Kimmel P, Ikizler T, Hsu C, Himmelfarb J, Cantley L, Parikh C. Urine Proteomic Signatures of Kidney Function Decline after Hospitalization. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20245v3jz4vr. DOI: 10.1681/asn.20245v3jz4vr.
- Efficacy and Safety of Belimumab in Severe Lupus Nephritis: A Retrospective Single-Center StudyAierken A, Zhuang J, Yang S, Yalikun D, Xu C, Zhang C, Tian X, Jiang H. Efficacy and Safety of Belimumab in Severe Lupus Nephritis: A Retrospective Single-Center Study. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.202486qykah2. DOI: 10.1681/asn.202486qykah2.
- Atypical Hemolytic Uremic Syndrome with Peripheral GangreneAierken A, Muhetaer G, Yang S, Zhuang J, Jiang H, Tian X. Atypical Hemolytic Uremic Syndrome with Peripheral Gangrene. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.20244hj831a8. DOI: 10.1681/asn.20244hj831a8.
- Podocytic Infolding Glomerulopathy: A Systematic Report of 44 CasesShen Z, Zhang C, Zhuang J, Qu Y, Tian X, Jiang H. Podocytic Infolding Glomerulopathy: A Systematic Report of 44 Cases. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024y382k1hb. DOI: 10.1681/asn.2024y382k1hb.
- Kidney Stone Incidence in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)Ostrow A, Gregory A, Kline T, Harris P, Dahl N, Erickson B, Nowak K, Torres V, Goldfarb D, Gitomer B, Chonchol M. Kidney Stone Incidence in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024nvt3dy6d. DOI: 10.1681/asn.2024nvt3dy6d.
- Characterization of GANAB Phenotype in Patients with ADPKD Using Advanced Imaging BiomarkersDebeh F, Rangarajan V, Ghanem A, Borghol A, Paul S, Alkhatib B, Nader N, Gregory A, Yang H, Hanna C, Dahl N, Kline T, Harris P, Chebib F. Characterization of GANAB Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024xrre28mc. DOI: 10.1681/asn.2024xrre28mc.
- Cystic Phenotypes Associated with Monoallelic COL4A3/A4/A5 Pathogenic Variants Identified in a Population-Based CohortSohi G, Elbarougy D, Yang H, Schauer R, McDonnell S, Frank J, Ma J, Dahl N, Hogan M, Torres V, Harris P. Cystic Phenotypes Associated with Monoallelic COL4A3/A4/A5 Pathogenic Variants Identified in a Population-Based Cohort. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.202460cgtrgd. DOI: 10.1681/asn.202460cgtrgd.
- External and Temporal Validation of Acute Tubulointerstitial Nephritis (AIN) Diagnostic Index: An Electronic Health Record-Based Multivariable Diagnostic Model for Assessing Probability of Acute Interstitial Nephritis on Kidney BiopsyShelton K, Menez S, Shaw M, Kent C, Bitzel J, Philbrook H, Wilson F, Hu D, Wen Y, Parikh C, Moledina D. External and Temporal Validation of Acute Tubulointerstitial Nephritis (AIN) Diagnostic Index: An Electronic Health Record-Based Multivariable Diagnostic Model for Assessing Probability of Acute Interstitial Nephritis on Kidney Biopsy. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024z9c9373z. DOI: 10.1681/asn.2024z9c9373z.
- Association of Hepatorenal Syndrome-Acute Kidney Injury with Mortality in Patients with Cirrhosis Requiring Renal Replacement TherapyCama-Olivares A, Ouyang T, Takeuchi T, St. Hillien S, Robinson J, Chung R, Cullaro G, Karvellas C, Levitsky J, Orman E, Patidar K, Regner K, Saly D, Sawinski D, Sharma P, Teixeira J, Ufere N, Velez J, Wadei H, Wahid N, Allegretti A, Neyra J, Belcher J, Cama-Olivares A, Ouyang T, Takeuchi T, St. Hillien S, Robinson J, Chung R, Cullaro G, Karvellas C, Levitsky J, Orman E, Patidar K, Regner K, Saly D, Sawinski D, Sharma P, Teixeira J, Ufere N, Velez J, Wadei H, Wahid N, Allegretti A, Neyra J, Belcher J. Association of Hepatorenal Syndrome-Acute Kidney Injury with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy. Kidney360 2024, 6: 247-256. PMID: 39348201, PMCID: PMC11882256, DOI: 10.34067/kid.0000000589.